Generate a tailored SOP for Dr. Arisbel Gondin. Improve your application with a focused, well-structured draft.
Arisbel Batista Gondin is an early-career researcher at the Monash Institute of Pharmaceutical Sciences, with a focus on Drug Discovery and Structural Biology of G protein-coupled receptors (GPCRs). He completed a joint PhD program in GPCR Molecular Pharmacology and Drug Discovery from 2014 to 2018. Under the supervision of internationally recognized scholars, his research characterized the molecular mechanisms underlying mu-opioid receptor activation, resulting in six published research articles. His work utilized advanced fluorescent and luminescent technologies and single-molecule imaging techniques to provide evidence of distinct phosphorylation patterns caused by synthetic versus endogenous opioids. Dr. Gondin's research challenges conventional views of the therapeutic profiles of ligands and highlights the potential for new generation biased ligands with improved therapeutic windows. He has presented his findings at leading international conferences in GPCR pharmacology. Currently, he is engaged in postdoctoral training supervised by experts in the field, further aligning his work with the UN Sustainable Development Goals. His research interests include Molecular Pharmacology, GPCR biology, Structural Biology, and the development of nanobody biosensors.
Monash University • Melbourne, Australia
Investigating the molecular dynamics and pharmacological profiles of G protein-coupled receptors, focusing on drug discovery.
Requirements are standardized across the Faculty of Information Technology for most Master's programs including Computer Science and Data Science.